Dual targeting of MDM2 and BCL2 as a therapeutic strategy in neuroblastoma

Abstract excerpt

// Alan Van Goethem 1, 2 , Nurten Yigit 1, 2 , Myrthala Moreno-Smith 3 , Sanjeev A. Vasudevan 3 , Eveline Barbieri 3 , Frank Speleman 1, 2 , Jason Shohet 3 , Jo Vandesompele 1, 2, 4 and Tom Van Maerken 1, 2 1 Center for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium 2 Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium 3 Department of Pediatrics, Section of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer-related Molecular Pathways
• Share to Neuroblastoma Research and Treatments
• Share to Protein Degradation and Inhibitors